Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

In a recent study posted to the bioRxiv* preprint server, the researchers compared the efficiency of monovalent and bivalent messenger ribonucleic acid (mRNA) vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

from Google Alert - health https://ift.tt/FVtydI9
via IFTTT